Advaxis Research Reception at SITC 2016 to Review Recent AXAL Highlights and the AXAL-Durvalumab Combination Poster
October 11, 2016 08:00 ET
|
Advaxis
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company...
Advaxis CSO Invited to Speak at Immune Profiling World Congress
October 06, 2016 08:00 ET
|
Advaxis
PRINCETON, N.J., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Robert Petit, Ph.D.,...
Advaxis Appoints Christopher Duke as Chief Operating Officer
October 03, 2016 08:00 ET
|
Advaxis
Greg Mayes Becomes Company’s First Chief Business Officer PRINCETON, N.J., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer...
Advaxis’ Lm Technology Immunotherapies to be Showcased in Three Poster Presentations at SITC Annual Meeting
September 26, 2016 15:45 ET
|
Advaxis
PRINCETON, N.J., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced three poster...
Advaxis to Present at the Aegis Annual Growth Conference
September 19, 2016 16:30 ET
|
Advaxis
PRINCETON, N.J., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Robert Petit, Ph.D.,...
Advaxis Unveils State-of-the-art Manufacturing Facility, Laboratory to Produce and Develop Novel Immuno-Oncology Therapeutics
September 12, 2016 08:00 ET
|
Advaxis
NJ Gov. Christie cuts ribbon, commends Advaxis milestone PRINCETON, N.J., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer...
N.J. Gov. Christie to Attend Advaxis Ribbon Cutting for New Manufacturing/Laboratory Facility in Princeton
September 08, 2016 14:28 ET
|
Advaxis
MEDIA ADVISORY, Sept. 08, 2016 (GLOBE NEWSWIRE) -- WHAT:Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, will unveil its new...
Advaxis to Present at Rodman & Renshaw 18th Annual Global Investment Conference
September 06, 2016 08:00 ET
|
Advaxis
PRINCETON, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J....
Advaxis to Participate in Cervivor School
August 19, 2016 08:00 ET
|
Advaxis
Kim Dorney to give opening keynote to cervical cancer survivors PRINCETON, N.J., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS) a clinical-stage biotechnology company developing...
Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors
August 16, 2016 09:31 ET
|
Advaxis
PRINCETON, N.J., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has entered into a...